Evaluation of disc diffusion and MIC testing for determining susceptibility of Pseudomonas aeruginosa isolates to topical enrofloxacin/silver sulfadiazine.
Trott
D J
DJ
School of Veterinary Science, The University of Queensland, St Lucia QLD 4072, Australia. d.trott@mailbox.uq.edu.au
Moss
S M
SM
See
A M
AM
Rees
R
R
D000287:Administration, Topical; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D015169:Colony Count, Microbial / Q000662:veterinary; D004283:Dog Diseases / Q000188:drug therapy / Q000382:microbiology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination; D000077422:Enrofloxacin; D024841:Fluoroquinolones / Q000494:pharmacology*; D010033:Otitis Media / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary*; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D012837:Silver Sulfadiazine / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D000077422:Enrofloxacin; D012837:Silver Sulfadiazine